FOLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 730
AS - Asia 572
EU - Europa 406
SA - Sud America 62
Continente sconosciuto - Info sul continente non disponibili 50
AF - Africa 28
OC - Oceania 1
Totale 1.849
Nazione #
US - Stati Uniti d'America 714
CN - Cina 308
IE - Irlanda 128
SG - Singapore 111
FI - Finlandia 60
DE - Germania 51
RU - Federazione Russa 51
VN - Vietnam 51
BR - Brasile 45
HK - Hong Kong 40
IT - Italia 33
FR - Francia 22
ZA - Sudafrica 22
IN - India 17
GB - Regno Unito 14
JP - Giappone 12
ES - Italia 11
CA - Canada 9
SE - Svezia 9
PL - Polonia 7
BD - Bangladesh 6
MX - Messico 5
AL - Albania 4
CO - Colombia 4
IQ - Iraq 4
TR - Turchia 4
AR - Argentina 3
BO - Bolivia 3
IR - Iran 3
LT - Lituania 3
SA - Arabia Saudita 3
VE - Venezuela 3
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ID - Indonesia 2
KH - Cambogia 2
NL - Olanda 2
PH - Filippine 2
TN - Tunisia 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
PK - Pakistan 1
PT - Portogallo 1
SL - Sierra Leone 1
UA - Ucraina 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 1.799
Città #
Dublin 128
Chandler 106
Beijing 77
San Jose 71
Singapore 71
Ashburn 65
Dallas 61
Nanjing 58
Hong Kong 40
Helsinki 36
Boardman 31
Nanchang 23
Jacksonville 22
Los Angeles 22
Ho Chi Minh City 21
Johannesburg 20
Shenyang 18
Tianjin 18
Princeton 17
Hebei 16
Lawrence 16
Munich 15
Changsha 14
Lauterbourg 14
Medford 13
New York 13
Pavia 13
Hanoi 12
Shanghai 12
Tokyo 12
Wilmington 12
Council Bluffs 11
Jiaxing 10
Turku 10
Chennai 7
Hangzhou 7
Redondo Beach 7
Warsaw 7
Buffalo 6
Falkenstein 6
Piscataway 6
Santa Clara 6
São Paulo 6
Chicago 5
Houston 5
Moscow 5
Norwalk 5
Padua 5
San Francisco 5
Da Nang 4
Frankfurt am Main 4
Pune 4
Tamm 4
Ankara 3
Atlanta 3
Bexley 3
Brasília 3
Haiphong 3
London 3
Milan 3
Montreal 3
Orem 3
Rio de Janeiro 3
Stockholm 3
Tirana 3
Woodbridge 3
Zhengzhou 3
Amsterdam 2
Brooklyn 2
Cairo 2
Charleston 2
Denver 2
Fremont 2
Fuzhou 2
La Paz 2
Manchester 2
Manila 2
Medina 2
Ningbo 2
Pasto 2
Phnom Penh 2
Poplar 2
Querétaro 2
Raleigh 2
Seattle 2
Shepherdsville 2
Taizhou 2
Thanh Hóa 2
Toronto 2
Vilnius 2
Vinovo 2
Addis Ababa 1
Al Hillah 1
Amman 1
Andaraí 1
Ann Arbor 1
Arizona City 1
Babol 1
Baghdad 1
Baku 1
Totale 1.301
Nome #
A patient with AL amyloidosis with negative free light chain results 129
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 128
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 126
Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis 125
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 120
A practical approach to the diagnosis of systemic amyloidoses 118
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 117
Prognostication of survival and progression to dialysis in AA amyloidosis 116
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 110
Presentation and outcome with second-line treatment in AL amyloidosis previously sensitive to nontransplant therapies 109
The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis 109
Urinary albumin to creatinine ratio in diagnosis and risk stratification of renal AL amyloidosis 105
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response 103
Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome 96
Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome 95
Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis 85
null 30
null 28
Totale 1.849
Categoria #
all - tutte 7.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202268 0 0 0 0 3 0 1 7 4 3 7 43
2022/2023309 33 32 7 18 21 31 0 10 149 1 6 1
2023/2024125 18 23 4 9 10 20 0 6 0 3 16 16
2024/2025282 9 18 12 6 5 31 18 3 68 17 40 55
2025/2026686 46 48 56 107 97 28 93 45 74 40 11 41
2026/202734 18 16 0 0 0 0 0 0 0 0 0 0
Totale 1.849